Supporting science

The NutriLeads team brings a diverse range of cross-disciplinary experience. The team is driven by a shared goal to develop large-scale food technologies that cost-effectively deliver scientifically substantiated, natural, innovative health ingredients to address top consumer health demands.

Structure dependent fermentation kinetics of dietary carrot rhamnogalacturonan-I in an in vitro gut model

Carrot RG-I Reduces Interindividual Differences between 24 Adults through Consistent Effects on Gut Microbiota Composition and Function Ex Vivo.

Effects of Dietary Supplementation with Carrot-Derived Rhamnogalacturonan-I (cRG-I) on Accelerated Protective Immune Responses and Quality of Life in Healthy Volunteers Challenged with Rhinovirus in a Randomized Trial (Mckay et al, 2022)

Nutrition and immunomodulation – Focus on the dietary fiber RG-I Rhamnogalacturonan-I trains the immune system and accelarates immune responses.

“The Dietary Intake of Carrot-Derived Rhamnogalacturonan-I Accelerates and Augments the Innate Immune and Anti-Viral Interferon Response to Rhinovirus Infection and Reduces Duration and Severity of Symptoms in Humans in a Randomized Trial” (Lutter et al.,

“Consistent Prebiotic Effects of Carrot RG-I on the Gut Microbiota of Four Human Adult Donors in the SHIME® Model despite Baseline Individual Variability” (van den Abbeele et al. 2021)

“Development of an affordable, sustainable and efficacious plant-based immunomodulatory food ingredient based on bell pepper or carrot RG-I pectic polysaccharides” (McKay et al., 2021)

Effect of Rhamnogalacturonan-I on Anti-Viral Response in Healthy Subjects (Lutter et al., 2021) (abstract)

Ingestion, Immunity and Infection: Nutrition and Viral Respiratory Tract Infections

cRG-I selectively modulates human gut microbiota while promoting gut barrier integrity (van den Abbeele et al., 2020)

Our investors

Goeie Grutten